Regulations covering public health should override personal rights and the country cannot wait any more for a good public health law. The health care industry, including institutions of medical education, hospitals and pharmaceutical businesses, have grown into behemoths that can do considerable harm in the absence of independent and effective regulatory systems. While there are no success stories in the regulation of any kind of industry in India, I will focus...

India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...

The prevalence is 18 per cent in South India, says UNAIDS report India houses half of Asia's HIV patients and is way ahead of China in disease burden. It also finds a place in the list of 22 countries prioritised for preventing mother to child transmission infection, according to the latest UNAIDS report, drafted jointly with the United Nations Children's Fund (UNICEF) and the World Health Organisation (WHO). About 48 lakh people...

-The Times of India   One in every five Indian adults living in urban cities suffers not only from hypertension but also diabetes. In Maharashtra, more disturbingly, one in three persons is struck by the twin epidemic. These are some of the highlights of India's largest clinic-based survey to assess the prevalence of diabetes and hypertension. The findings of the study, called Screening India's Twin Epidemic (SITE), were announced on Monday in...